Időskori makuladegeneráció: vizsgálatok itt: Egyesült Államok
95 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleDevelopment and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)
- Where
- Irvine
- Életkor
- 18 év and over
- People
- 25
- Run by
- Ray Therapeutics, Inc.
See details and how to joinNCT07502664 - No phaseTaking peopleProgression of Early Atrophic Lesions
- Where
- Salt Lake City
- Életkor
- 50 év and over
- People
- 125
- Run by
- University of Utah
See details and how to joinNCT05959005 - No phaseTaking peopleReal-World Evaluation of AI Enabled Multi-Spectral Imaging (MSI) for AMD Biomarker Detection
- Where
- Woodbridge
- Életkor
- 40 év and over
- People
- 1000
- Run by
- AI-Spectral
See details and how to joinNCT07446582 - No phaseTaking peopleActive AMD Study to Improve Function in Veterans
- Where
- Decatur
- Életkor
- 65 év to 89 év
- People
- 70
- Run by
- VA Office of Research and Development
See details and how to joinNCT05932069 - No phaseTaking peopleFactors in Learning And Plasticity: Macular Degeneration
- Where
- Birmingham
- Életkor
- 18 év to 89 év
- People
- 60
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05454124 - 1. fázisTaking peopleA Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses
- Where
- Dallas
- Életkor
- 18 év to 50 év
- People
- 68
- Run by
- Aptabio Therapeutics, Inc.
See details and how to joinNCT07330674 - Korai 1. fázisTaking peopleFeasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
- Where
- Ann Arbor
- Életkor
- 18 év and over
- People
- 10
- Run by
- MediBeacon
See details and how to joinNCT04008121 - 2. fázisTaking peopleDark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
- Where
- Boston
- Életkor
- 50 év to 85 év
- People
- 21
- Run by
- Massachusetts Eye and Ear Infirmary
See details and how to joinNCT04735263 - 1/2. fázisTaking peopleA Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD
- Where
- Edison
- Életkor
- 50 év to 85 év
- People
- 40
- Run by
- Bionic Sight LLC
See details and how to joinNCT07158775 - 1/2. fázisTaking peopleA Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Where
- Aurora, Boston, Dallas, Miami, Portland
- Életkor
- 12 év to 65 év
- People
- 57
- Run by
- Splice Bio
See details and how to joinNCT06942572 - 3. fázisNot yet taking people in Egyesült ÁllamokA Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
- Where
- Abilene, Erie, Germantown, Phoenix, Springdale, Willow Park
- Életkor
- 50 év and over
- People
- 434
- Run by
- Rophibio, Inc.
See details and how to joinNCT06470373 - No phaseTaking peopleA Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
- Where
- Dallas
- Életkor
- 18 év and over
- People
- 30
- Run by
- Nanoscope Therapeutics Inc.
See details and how to joinNCT06805474 - No phaseTaking peopleNYSCF Scientific Discovery Biobank
- Where
- New York
- Életkor
- 30 nap and over
- People
- 10 000
- Run by
- New York Stem Cell Foundation Research Institute
See details and how to joinNCT06203106 - 1. fázisTaking peopleStudy to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
- Where
- Augusta, Carmel, Deerfield Beach, Erie, Fargo, Manchester, Philadelphia
- Életkor
- 50 év and over
- People
- 45
- Run by
- Caregen Co. Ltd.
See details and how to joinNCT06132035 - No phaseTaking peopleObservational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
- Where
- Irvine
- Életkor
- 18 év and over
- People
- 120
- Run by
- Ray Therapeutics, Inc.
See details and how to joinNCT06375239 - No phaseTaking peopleMulticenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Where
- Asheville, Birmingham, Cleveland, Eatontown, Houston, Lawrence, Loma Linda, Long Beach, Omaha, Sarasota
- Életkor
- 65 év and over
- People
- 125
- Run by
- VisionCare, Inc.
See details and how to joinNCT05438732 - No phaseTaking peopleNovel Glaucoma Diagnostics
- Where
- Philadelphia
- Életkor
- 18 év and over
- People
- 5000
- Run by
- Wills Eye
See details and how to joinNCT00286637 - 2. fázisCsak meghívásosLong-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
- Where
- Baltimore, Boston, Germantown, Philadelphia, Phoenix, Reno, Santa Barbara, The Woodlands
- Életkor
- 50 év and over
- People
- 865 worldwide
- Run by
- AbbVie
See details and how to joinNCT03999801 · EU 2023-505750-17-00 - No phaseTaking peopleOCT Angiography in Wet AMD
- Where
- Portland
- Életkor
- 50 év to 100 év
- People
- 160
- Run by
- Oregon Health and Science University
See details and how to joinNCT02253030 - No phaseCsak meghívásosPost-Approval Study of the Implantable Miniature Telescope
- Where
- Ann Arbor, Atlanta, Beverly Hills, Chandler, Chesterfield, Eugene, Fullerton, Loma Linda, McAllen, New York, Parker, Pensacola, Phoenix, Sacramento, Sarasota
- Életkor
- 65 év and over
- People
- 770
- Run by
- VisionCare, Inc.
See details and how to joinNCT01757132